Comparison of Histoacryl® plus Lipiodol® versus Histoacryl® plus vitamin D3 in the management of isolated fundal varices: A retrospective comparative study

  • Dilaram Khan Gastroenterology Department, LRH, Peshawar
  • Naveed Aamir Gastroenterology Department, LRH, Peshawar
  • Muhammad Kamran Hassan
  • Farman Ali Gastroenterology Department, LRH, Peshawar
  • Fakhare Alam
  • Hashmatullah Khan Gastroenterology Department, LRH, Peshawar
Keywords: Fundal varices, Histoacryl (N-butyl-2 -Cyanoacrylate), Vitamin D3, Lipoidol


Objective: According to recent guidelines Histoacryl® (N-butyl-2 -Cyanoacrylate) injection is the first line therapy for the endoscopic obliteration of gastric varices. Lipiodol is commonly used to facilitate injection Histoacryl® but it is expensive. In this study we compare Lipiodol with Vitamin D3 injection as priming agents for Histoacryl injection in terms of efficacy and safety in the management of isolated fundal varices.

Methods: This is a retrospective comparative study conducted at Gastroenterology Unit, Lady Reading hospital Peshawar. Patients’ information was collected from March, 2012 to January, 2020 from medical records and statistically analyzed in terms of fundal varices obliteration, re-bleeding, mortality, and adverse events related to treatment.

Results: From March, 2012 to January, 2020, 171 patients met the criteria. 7 cases lost follow up, and all the cases in both groups were treated successfully. There were no adverse events related to procedure in either group. Twenty six patients developed upper GI re-bleeding, which did not differ significantly betweenthe twogroups. There was also no difference between the groups in terms of treatment failure, complications, varices obliteration, and mortality.

Conclusion: Vitamin D3 is as safe and effective as Lipoidol when used as priming agent for Histoacryl injection for obliteration of isolated fundal varices and can be used as a cheaper alternative to Lipoidol.


1. Silverstein FE, Gilbert DA, Tedesco FJ, Buenger NK, Persing J. The national ASGE survey on upper gastrointestinal bleeding. I. Study design and baseline data. Gastrointest Endosc. 1981;27(2):73‐79. doi:10.1016/s0016-5107(81)73155-9
2. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, Pandya P, Sitaraman S, Shen J. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. The American journal of gastroenterology. 2003 Mar 1;98(3):653-9.
3. Sharma P, Sarin SK. Improved survival with the patients with variceal bleed. International journal of hepatology. 2011 Jul 7;2011.
4. Helmy A, Hayes PC. Current endoscopic therapeutic options in the management of variceal bleeding. Alimentary pharmacology & therapeutics. 2001 May 15;15(5):575-94.
5. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long‐term follow‐up study in 568 portal hypertension patients. Hepatology. 1992 Dec;16(6):1343-9.
6. Northup PG, Caldwell SH. Treatment of bleeding gastric varices. Journal of gastroenterology and hepatology. 2005 Nov;20(11):1631-3.
7. Trudeau W, Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices. Gastrointestinal endoscopy. 1986 Aug 1;32(4):264-8.
8. Teng W, Chen WT, Ho YP, Jeng WJ, Huang CH, Chen YC, Lin SM, Chiu CT, Lin CY, Sheen IS. Predictors of mortality within 6 weeks after treatment of gastric variceal bleeding in cirrhotic patients. Medicine. 2014 Dec;93(29).
9. Kim T, Shijo H, Kokawa H, Tokumitsu H, Kubara K, Ota K, Akiyoshi N, Iida T, Yokoyama M, Okumura M. Risk factors for hemorrhage from gastric fundal varices. Hepatology. 1997 Feb;25(2):307-12.
10. Lee CH, Lee JH, Choi YS, Paik SW, Sinn DH, Lee CY, Koh KC, Gwak GY, Choi MS, Yoo BC. Natural history of gastric varices and risk factors for bleeding. The Korean journal of hepatology. 2008 Sep;14(3):331-41.
11. Hashizume M, Kitano S, Yamaga H, Koyanagi N, Sugimachi K. Endoscopic classification of gastric varices. Gastrointestinal Endoscopy. 1990 May 1;36(3):276-80.
12. Kanagawa H, Mima S, Kouyama H, GOTOH K, UCHIDA T, OKUDA K. Treatment of gastric fundal varices by balloon‐occluded retrograde transvenous obliteration. Journal of gastroenterology and hepatology. 1996 Jan;11(1):51-8.
13. Rajoriya N, Forrest EH, Gray J, Stuart RC, Carter RC, McKay CJ, Gaya DR, Morris AJ, Stanley AJ. Long-term follow-up of endoscopic Histoacryl glue injection for the management of gastric variceal bleeding. QJM: An International Journal of Medicine. 2011 Jan 1;104(1):41-7.
14. Kojima K, Imazu H, Matsumura M, Honda Y, Umemoto N, Moriyasu H, Orihashi T, Uejima M, Morioka C, Komeda Y, Uemura M. Sclerotherapy for gastric fundal variceal bleeding: Is complete obliteration possible without cyanoacrylate?. Journal of gastroenterology and hepatology. 2005 Nov;20(11):1701-6.
15. Fry LC, Neumann H, Olano C, Malfertheiner P, Mönkemüller K. Efficacy, complications and clinical outcomes of endoscopic sclerotherapy with N-butyl-2-cyanoacrylate for bleeding gastric varices. Digestive Diseases. 2008;26(4):300-3.
16. Taghavi SA, Eshraghian A, Hamidpour L, Moshfe MJ. Endoscopic cyanoacrylate injection for the treatment of bleeding gastric varices: the first Iranian series.
17. Linhares MM, Matone J, Matos D, Sakamoto FI, Caetano Jr EM, Sato NY, Herani Filho B, Aramayo AL, Goldenberg A, Lopes-Filho GD. Endoscopic treatment of bleeding gastric varices using large amount of N-butyl-2-cyanoacrylate under fluoroscopic guidance. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 2008 Oct 1;18(5):441-4.
18. Nasir MB, Mushtaq J, Amjad I, ul Haq I, Rasool S, ul Hassan G. Histoacryl®(N-butyl-2-cyanoacrylate) injection mixed with olive oil for endoscopic treatment of gastric varices–an equally safe alternative. Journal of Fatima Jinnah Medical University. 2018;12(3).
19. SIGN. Management of acute upper and lower GI bleeding. SIGN Guideline No. 105, ISBN 978 1 905813 37 7, September 2008.
20. Soares‐Weiser K, Brezis M, Tur‐Kaspa R, Leibovici L. Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. Cochrane Database of Systematic Reviews. 2002(2).
21. Huang YH, Yeh HZ, Chen GH, Chang CS, Wu CY, Poon SK, Lien HC, Yang SS. Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointestinal endoscopy. 2000 Aug 1;52(2):160-7.
22. Iwase H, Maeda O, Shimada M, Tsuzuki T, Peek Jr RM, Nishio Y, Ando T, Ina K, Kusugami K. Endoscopic ablation with cyanoacrylate glue for isolated gastric variceal bleeding. Gastrointestinal endoscopy. 2001 May 1;53(6):585-92.
23. Seewald S, Naga M, Omar S, Okasha H, Imazu H, Groth S, Seitz U, Fouad A, Foda A, Saeed M, Gerges A. Standardized injection technique and regimen minimizes complication and ensures safety of N-butyl-2-cyanoacrylate injection for the treatment of gastric fundal varices. Gastrointestinal Endoscopy. 2005 Apr 1;61(5):AB91.
24. Seewald S, Ang TL, Imazu H, Naga M, Omar S, Groth S, Seitz U, Zhong Y, Thonke F, Soehendra N. A standardized injection technique and regimen ensures success and safety of N-butyl-2-cyanoacrylate injection for the treatment of gastric fundal varices (with videos). Gastrointestinal endoscopy. 2008 Sep 1;68(3):447-54.
25. Kang EJ, Jeong SW, Jang JY, Cho JY, Lee SH, Kim HG, Kim SG, Kim YS, Cheon YK, Cho YD, Kim HS. Long-term result of endoscopic Histoacryl®(N-butyl-2-cyanoacrylate) injection for treatment of gastric varices. World journal of gastroenterology: WJG. 2011 Mar 21;17(11):1494.
26. Helmy A, Hayes PC. Current endoscopic therapeutic options in the management of variceal bleeding. Alimentary pharmacology & therapeutics. 2001 May 15;15(5):575-94.
27. Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology. 2001 May 1;33(5):1060-4.
28. Maluf-Filho F, Sakai P, Ishioka S, Matuguma SE. Endoscopic sclerosis versus cyanoacrylate endoscopic injection for the first episode of variceal bleeding: a prospective, controlled, and randomized study in Child-Pugh class C patients. Endoscopy. 2001 May;33(05):421-7.
29. Paik CN, Kim SW, Lee IS, Park JM, Cho YK, Choi MG, Chung IS. The therapeutic effect of cyanoacrylate on gastric variceal bleeding and factors related to clinical outcome. Journal of clinical gastroenterology. 2008 Sep 1;42(8):916-22.
30. Lo GH, Liang HL, Chen WC, Chen MH, Lai KH, Hsu PI, Lin CK, Chan HH, Pan HB. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric varicealrebleeding. Endoscopy. 2007 Aug;39(08):679-85.
31. Saracco G, Giordanino C, Roberto N, Ezio D, Luca T, Caronna S, Carucci P, Venon WD, Barletti C, Bruno M, De Angelis C. Fatal multiple systemic embolisms after injection of cyanoacrylate in bleeding gastric varices of a patient who was noncirrhotic but with idiopathic portal hypertension. Gastrointestinal endoscopy. 2007 Feb 1;65(2):345-7.
32. Hwang SS, Kim HH, Park SH, Kim SE, Im Jung J, Ahn BY, Kim SH, Chung SK, Park YH, Choi KH. N-butyl-2-cyanoacrylate pulmonary embolism after endoscopic injection sclerotherapy for gastric variceal bleeding. Journal of computer assisted tomography. 2001 Jan 1;25(1):16-22.
How to Cite
Khan D, Aamir N, Hassan M, Ali F, Alam F, Khan H. Comparison of Histoacryl® plus Lipiodol® versus Histoacryl® plus vitamin D3 in the management of isolated fundal varices: A retrospective comparative study. JRMC [Internet]. 31Mar.2022 [cited 27May2022];26(1):30-3. Available from: